CEL-SCI Corporation (AMEX:CVM) price on Thursday, August 05, rose 4.76% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $9.25.
A look at the stock’s price movement, the close in the last trading session was $8.83, moving within a range at $8.53 and $9.33. The beta value (5-Year monthly) was 2.26. Turning to its 52-week performance, $40.91 and $7.08 were the 52-week high and 52-week low respectively. Overall, CVM moved 6.57% over the past month.
CEL-SCI Corporation’s market cap currently stands at around $383.50 million, with investors looking forward to this quarter’s earnings report slated for Aug 09, 2021 – Aug 13, 2021. Analysts project the company’s earnings per share (EPS) to be -$0.13, which has seen fiscal year 2021 EPS growth forecast to increase to -$0.66 and about -$0.23 for fiscal year 2022.
Analysts have a consensus estimate of $100k for the company’s revenue for the quarter, with a low and high estimate of $100k and $100k respectively. Wall Street analysts have also projected the company’s year-on-year revenue for 2021 to grow to $200k, representing a -64.20% decline on that reported in the last financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that CVM is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend CVM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CVM’s current price about 14.40% and -38.21% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 43.85, while 7-day volatility ratio is 6.56% and 7.79% in the 30-day chart. Further, CEL-SCI Corporation (CVM) has a beta value of 2.17, and an average true range (ATR) of 1.27. Analysts have given the company’s stock an average 52-week price target of $12.00, forecast between a low of $12.00 and high of $12.00. Looking at the price targets, the low is -29.73% off current price level while to achieve the yearly target high, price needs to move -29.73%. Nonetheless, investors will most likely welcome a -29.73% jump to $12.00 which is the analysts’ median price.
In the market, a comparison of CEL-SCI Corporation (CVM) and its peers suggest the former has performed considerably stronger. Data shows CVM’s intraday price has changed 4.76% in last session and -24.61% over the past year. Comparatively, CASI Pharmaceuticals Inc. (CASI) has moved 1.69% on the day and only -37.50% in the past 12 months. Moreover, Johnson & Johnson (JNJ) is also up 0.19% in trading on the day while keeping a an uptrend of 17.04% over the past year. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are up 0.60% and 0.78% respectively in the last trading.
If we refocus on CEL-SCI Corporation (AMEX:CVM), historical trading data shows that trading volumes averaged 0.79 million over the past 10 days and 1.86 million over the past 3 months. The company’s latest data on shares outstanding shows there are 40.05 million shares.
The 1.30% of CEL-SCI Corporation’s shares are in the hands of company insiders while institutional holders own 33.30% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 10.09 million on May 27, 2021, giving us a short ratio of 15.18. The data shows that as of May 27, 2021 short interest in CEL-SCI Corporation (CVM) stood at 24.67% of shares outstanding, with shares short rising to 10.0 million registered in Apr 29, 2021. Current price change has pushed the stock -20.67% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CVM stock continues to rise going into the next quarter.